4.0
27 Aug 2014
Former employee, more than 1 year
Moscow, Moskva
Recommend
CEO approval
Business outlook
Pros
Respectable company with the good portfolio and stable diverse business.
Cons
Compensation policy seems slightly below the market. Slight reputational problem (globally - compliance, and also locally - vaccines trials, Volgograd).